Sign Up Today and Learn More About BioVersys Stock
Invest in or calculate the value of your shares in BioVersys or other pre-IPO companies through EquityZen's platform.
BioVersys Stock (BIOV)
BioVersys is a privately held Swiss biopharmaceutical company.
About BioVersys Stock
Founded
2008
Industries
Science and Engineering, Health Care, Biotechnology
BioVersys Press Mentions
Stay in the know about the latest news on BioVersys
GSK expands collaboration with BioVersys on tuberculosis asset alpibectir
seekingalpha • May 19, 2024
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF ...
morningstar • May 19, 2024
GSK commits to further support of BioVersys' TB drug
pharmaphorum • May 19, 2024
GSK joins BioVersys’ investors in series C extension round
startupticker • May 08, 2024
BioVersys–SEVERAL: investment, 202403 financing round Series C extension CHF12.3m bringing total Series C to CHF44.9m
life-sciences-europe • May 08, 2024
BioVersys Management
Leadership team at BioVersys
CSO
Sergio Lociuro
Chairman of the Board
Seng Chin Mah
Join now and verify your accreditation status to gain access to:
- BioVersys current valuation
- BioVersys stock price
- Available deals in BioVersys and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in BioVersys stock?
Accredited investors can buy pre-IPO stock in companies like BioVersys through EquityZen funds. These investments are made available by existing BioVersys shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BioVersys stock?
Shareholders can sell their BioVersys stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."